Dehydroepiandrosterone up-regulates the Adrenoleukodystrophy-related gene (ABCD2) independently of PPARα in rodents

作者: F. Gueugnon , C. Gondcaille , S. Leclercq , J. Bellenger , S. Bellenger

DOI: 10.1016/J.BIOCHI.2007.06.013

关键词:

摘要: X-linked adrenoleukodystrophy (X-ALD) is a neurodegenerative disease caused by mutations in the ABCD1 gene, which encodes peroxisomal ABC transporter, ALDP, supposed to participate transport of very long chain fatty acids (VLCFA). The adrenoleukodystrophy-related protein (ALDRP), encoded ABCD2 closest homolog ALDP and considered as potential therapeutic target since functional redundancy has been demonstrated between two proteins. Pharmacological induction Abcd2 fibrates through activation PPARalpha rodent liver. DHEA, most abundant steroid human, described activator also prohormone able mediate several genes. Here, we explored vitro vivo effects DHEA on expression transporters. We show that Abcd3 but not Abcd4 are induced primary culture rat hepatocytes DHEA-S. demonstrate inducible an 11-day treatment with liver male rodents brain, testes adrenals. Finally contrary Abcd3, mechanism independent PPARalpha.

参考文章(73)
Maurice Bugaut, Stephane Fourcade, Catherine Gondcaille, Fabien Gueugnon, Marianne Depreter, Frank Roels, Angela Netik, Johannes Berger, Pascal Martin, Thierry Pineau, Francoise Cadepond, Martine El Etr, Stephane Savary, Pharmacological induction of redundant genes for a therapy of X-ALD: phenylbutyrate and other compounds. Advances in Experimental Medicine and Biology. ,vol. 544, pp. 281- 291 ,(2003) , 10.1007/978-1-4419-9072-3_36
Stéphane Fourcade, Stéphane Savary, Sabrina Albet, Delphine Gauthé, Catherine Gondcaille, Thierry Pineau, Jérome Bellenger, Marc Bentejac, Andreas Holzinger, Johannes Berger, Maurice Bugaut, Fibrate induction of the adrenoleukodystrophy‐related gene (ABCD2) FEBS Journal. ,vol. 268, pp. 3490- 3500 ,(2001) , 10.1046/J.1432-1327.2001.02249.X
David J. Waxman, David P. Lapenson, Russell A. Prough, Stephanie Johnson Webb, Hui-Qiong Wu, Induction of microsomal and peroxisomal enzymes by dehydroepiandrosterone and its reduced metabolite in rats. Cancer Research. ,vol. 54, pp. 2878- 2886 ,(1994)
Paul A Lapchak, Dalia M Araujo, Preclinical development of neurosteroids as neuroprotective agents for the treatment of neurodegenerative diseases. International Review of Neurobiology. ,vol. 46, pp. 379- 397 ,(2001) , 10.1016/S0074-7742(01)46069-7
Carolyn D. Berdanier, John A. Parente, Michael K. McIntosh, Is dehydroepiandrosterone an antiobesity agent The FASEB Journal. ,vol. 7, pp. 414- 419 ,(1993) , 10.1096/FASEBJ.7.5.8462783
P.O. Seglen, Preparation of rat liver cells. III. Enzymatic requirements for tissue dispersion Experimental Cell Research. ,vol. 82, pp. 391- 398 ,(1973) , 10.1016/0014-4827(73)90357-1
K Kamijo, S Taketani, S Yokota, T Osumi, T Hashimoto, The 70-kDa peroxisomal membrane protein is a member of the Mdr (P-glycoprotein)-related ATP-binding protein superfamily. Journal of Biological Chemistry. ,vol. 265, pp. 4534- 4540 ,(1990) , 10.1016/S0021-9258(19)39595-X
Pamarthi F. Mohan, Joel S. Ihnen, Barry E. Levin, Margot P. Cleary, Effects of dehydroepiandrosterone treatment in rats with diet-induced obesity. Journal of Nutrition. ,vol. 120, pp. 1103- 1114 ,(1990) , 10.1093/JN/120.9.1103